Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson’s disease
暂无分享,去创建一个
Francesca Baglio | Giuseppe Baselli | Maria Marcella Laganà | Niels Bergsland | Raffaello Nemni | Laura Pelizzari | Mario Clerici | Federica Rossetto | M. Galli | G. Baselli | R. Nemni | M. Clerici | F. Rossetto | F. Baglio | N. Bergsland | M. M. Laganá | L. Pelizzari | Mirco Galli
[1] Christopher G. Goetz Chairperson,et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004 .
[2] G. E. Alexander,et al. Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.
[3] W. Poewe,et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.
[4] I. Rektorová,et al. Arterial spin labelling detects posterior cortical hypoperfusion in non-demented patients with Parkinson’s disease , 2017, Journal of Neural Transmission.
[5] P. Pollak,et al. Levodopa does not change cerebral vasoreactivity in Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.
[6] J. Bart,et al. Blood–brain barrier dysfunction in parkinsonian midbrain in vivo , 2005, Annals of neurology.
[7] E. Miyoshi,et al. Abnormal Cerebrovascular Reactivity in Patients with Parkinson's Disease , 2015, Parkinson's disease.
[8] S. McEwen,et al. Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease , 2013, The Lancet Neurology.
[9] C. Clarke,et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[10] J. Woulfe,et al. Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] T. Spires-Jones,et al. A brain boost to fight Alzheimer's disease , 2018, Science.
[12] Alfonso Barrós-Loscertales,et al. Compensatory cortical mechanisms in Parkinson's disease evidenced with fMRI during the performance of pre-learned sequential movements , 2007, Brain Research.
[13] M. Hallett,et al. Parkinson’s disease as a system-level disorder , 2016, npj Parkinson's Disease.
[14] P. Calabresi,et al. Complexity of Motor Sequences and Cortical Reorganization in Parkinson's Disease: A Functional MRI Study , 2013, PloS one.
[15] S. Rauch,et al. Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. , 2005, The American journal of psychiatry.
[16] Berislav V. Zlokovic,et al. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.
[17] Manus J. Donahue,et al. Neuroimaging of vascular reserve in patients with cerebrovascular diseases , 2017, NeuroImage.
[18] L. McGuinness,et al. Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease , 2015, Neurobiology of Disease.
[19] M. Oda,et al. Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features. , 2005, Parkinsonism & related disorders.
[20] A. Członkowska,et al. Cerebral vasomotor reactivity in neurodegenerative diseases. , 2016, Neurologia i neurochirurgia polska.
[21] T. Grabowski,et al. Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[22] W. Poewe,et al. The reorganization of functional architecture in the early-stages of Parkinson's disease. , 2018, Parkinsonism & related disorders.
[23] Richard Watts,et al. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. , 2011, Brain : a journal of neurology.
[24] Marcella Laiacona,et al. Montreal Cognitive Assessment (MoCA)-Italian version: regression based norms and equivalent scores , 2015, Neurological Sciences.
[25] Mark Jenkinson,et al. The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis , 2012, Human brain mapping.
[26] J. Labandeira-Garcia,et al. Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β , 2014, Experimental Neurology.
[27] Hong Yu,et al. Role of hyperactive cerebellum and motor cortex in Parkinson's disease , 2007, NeuroImage.
[28] M. Giannelli,et al. Hypoactivation of the primary sensorimotor cortex in de novo Parkinson’s disease , 2012, Neuroradiology.
[29] Iracema Leroi,et al. Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease , 2014, NeuroImage: Clinical.
[30] A. Rodriguez-Perez,et al. Dopamine‐Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.
[31] V. Blasi,et al. Functional brain changes in early Parkinson's disease during motor response and motor inhibition , 2011, Neurobiology of Aging.
[32] E. Hirsch,et al. Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian , 2005, Journal of Neural Transmission.
[33] M. Mallar Chakravarty,et al. Multi-contrast unbiased MRI atlas of a Parkinson’s disease population , 2015, International Journal of Computer Assisted Radiology and Surgery.
[34] S. Gatzonis,et al. Parkinson's disease pathogenesis, evolution and alternative pathways: A review. , 2018, Revue neurologique.
[35] Whitney B. Pope,et al. Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke — Comparison with dynamic susceptibility contrast enhanced perfusion imaging☆ , 2013, NeuroImage: Clinical.
[36] Y. Sohn,et al. Cerebral microbleeds in patients with Parkinson’s disease , 2014, Journal of Neurology.
[37] Y. Carmi,et al. The role IL-1 in tumor-mediated angiogenesis , 2014, Front. Physiol..
[38] R. Barker,et al. Parkinson's disease and healthy aging: Independent and interacting effects on action selection , 2010, Human brain mapping.
[39] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[40] Y. Itoyama,et al. Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease , 2001, Journal of the Neurological Sciences.
[41] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[42] Peiying Liu,et al. Impaired cerebrovascular reactivity in multiple sclerosis. , 2014, JAMA neurology.
[43] Asmaa M S Gomaa,et al. Vulnerability of glia and vessels of rat substantia nigra in rotenone Parkinson model , 2018, Ultrastructural pathology.
[44] Mark W. Woolrich,et al. Variational Bayesian Inference for a Nonlinear Forward Model , 2020, IEEE Transactions on Signal Processing.
[45] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.